| EPB043 | Trends in QGIT positivity among newly diagnosed people living with HIV in South Africa: results from the TEKO trial | E-poster | Tuberculosis: Prevention, diagnosis, treatment |
| EPB044 | Applying Quality Improvement methodology using DMAIC for process-based strengthening of TB case finding among PLHIV at ART clinic in the University of Nigeria Teaching Hospital, Enugu, Nigeria | E-poster | Tuberculosis: Prevention, diagnosis, treatment |
| EPB045 | An estimate of the global burden of HIV-associated cryptococcal infection in adults in 2020 | E-poster | Opportunistic infections (excluding TB): Bacterial, non-TB mycobacterial, viral and parasitic infections |
| EPB046 | Hematological toxicity of amphotericin B deoxycholate-based induction therapy in patients with HIV-associated talaromycosis | E-poster | Opportunistic infections (excluding TB): Bacterial, non-TB mycobacterial, viral and parasitic infections |
| EPB047 | Voriconazole or amphotericin B deoxycholate: which is the preferred induction therapy in HIV-infected patients with talaromycosis? | E-poster | Opportunistic infections (excluding TB): Bacterial, non-TB mycobacterial, viral and parasitic infections |
| EPB048 | Immunogenicity and safety of yellow fever vaccination in people living with HIV | E-poster | Opportunistic infections (excluding TB): Bacterial, non-TB mycobacterial, viral and parasitic infections |
| EPB049 | Epidemiology of pneumonia in a multicenter cohort of people living with HIV | E-poster | Opportunistic infections (excluding TB): Bacterial, non-TB mycobacterial, viral and parasitic infections |
| EPB050 | Prevalence and determinants of asymptomatic Leishmania infection in HIV-positive people and progression to symptomatic visceral leishmaniasis in Bihar, India | E-poster | Opportunistic infections (excluding TB): Bacterial, non-TB mycobacterial, viral and parasitic infections |
| EPB051 | Understanding unsuccessful direct-acting antiviral hepatitis C treatment among people living with HIV from the International Collaboration on Hepatitis C Elimination in HIV Cohorts (InCHECH) | E-poster | Viral hepatitis C and other viral hepatitis (e.g., A, B, D, E) |
| EPB052 | Acute HCV infection followed by spontaneous clearance impact on telomere shorting | E-poster | Viral hepatitis C and other viral hepatitis (e.g., A, B, D, E) |